Latest Insider Transactions at Exicure, Inc. (XCUR)
This section provides a real-time view of insider transactions for Exicure, Inc. (XCUR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EXICURE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EXICURE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2024
|
Dgp Co., Ltd. |
BUY
Open market or private purchase
|
Direct |
237,223
+21.83%
|
$711,669
$3.0 P/Share
|
|
Aug 16
2024
|
Josh Miller Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-2.13%
|
$0
$0.36 P/Share
|
|
May 16
2024
|
Josh Miller Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-2.52%
|
$0
$0.52 P/Share
|
|
Feb 29
2024
|
Dgp Co., Ltd. |
SELL
Open market or private sale
|
Direct |
3,400,000
-100.0%
|
$3,400,000
$1.32 P/Share
|
|
Feb 16
2024
|
Josh Miller Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-2.46%
|
$0
$0.6 P/Share
|
|
Nov 16
2023
|
Josh Miller Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-1.99%
|
$0
$0.56 P/Share
|
|
Aug 16
2023
|
Josh Miller Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-1.9%
|
$0
$0.83 P/Share
|
|
Jun 23
2023
|
Cbi Usa, Inc. |
SELL
Conversion of derivative security
|
Direct |
3,400,000
-80.6%
|
$3,400,000
$1.6 P/Share
|
|
May 16
2023
|
Josh Miller Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
185
-8.67%
|
$185
$1.07 P/Share
|
|
Dec 15
2022
|
Cbi Usa, Inc. |
BUY
Open market or private purchase
|
Direct |
3,400,000
+44.63%
|
$3,400,000
$1.6 P/Share
|
|
May 19
2022
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
1,472,126
+14.84%
|
$0
$0.19 P/Share
|
|
Dec 21
2021
|
Gates Frontier, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,268,619
-20.03%
|
$0
$0.24 P/Share
|
|
Nov 15
2021
|
Douglas E. Feltner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+33.33%
|
$0
$0.91 P/Share
|
|
Nov 15
2021
|
David A Giljohann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+16.25%
|
$0
$0.91 P/Share
|
|
Aug 27
2021
|
Elias D. Papadimas Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$10,000
$1.38 P/Share
|
|
May 14
2021
|
Douglas E. Feltner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+50.0%
|
$7,500
$1.27 P/Share
|
|
May 14
2021
|
David A Giljohann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+19.4%
|
$7,500
$1.27 P/Share
|
|
May 14
2021
|
Matthias Schroff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+50.0%
|
$7,500
$1.27 P/Share
|